Cargando…

Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma

Head & Neck Squamous Cell Carcinoma is one of the highest mortality factors in the world due to the lack of potential biomarker for early detection of disease. There is an urgent need for molecular marker involved in disease progression which remains suppressed normally, required for specificity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agnihotri, Vertica, Gupta, Abhishek, Kumar, Lalit, Dey, Sharmistha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052243/ https://www.ncbi.nlm.nih.gov/pubmed/32123232 http://dx.doi.org/10.1038/s41598-020-60811-y

Ejemplares similares

Effects of Tobacco Habits on the Polymorphism of NFKB1 and NFKB1A Gene of Head and Neck Squamous Cell Carcinoma in Indian Population
por: Gupta, Abhishek, et al.
Publicado: (2017)

Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
por: Sahu, Vishal, et al.
Publicado: (2019)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

Zejchho shla'-shla' : to lonhez da' chheyon chhio' toz /
por: González Dillon, Mónica
Publicado: (2013)

The Relationship between the HLA-G Polymorphism and sHLA-G Levels in Parental Pairs with High-Risk Pregnancy
por: Sipak, Olimpia, et al.
Publicado: (2019)

The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance
por: Hauer, Vanessa, et al.
Publicado: (2019)

Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer
por: Mejía-Guarnizo, Lidy Vannessa, et al.
Publicado: (2023)

Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion
por: Bortolotti, Daria, et al.
Publicado: (2021)

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
por: Xu, Danping, et al.
Publicado: (2021)

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients
por: Hoffmann, Oliver, et al.
Publicado: (2023)

Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker
por: Heidari, Mohammad Hassan, et al.
Publicado: (2017)

Evaluation of the Level of Salivary sHLA-G in Children Aged 3–5 Years with or without Dental Caries
por: Bijani, Mansoureh, et al.
Publicado: (2020)

Erratum to: Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker
por: Heidari, Mohammad Hassan, et al.
Publicado: (2017)

Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2022)

Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis
por: Rizzo, Roberta, et al.
Publicado: (2016)

Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
por: de Medeiros, Marcell Costa, et al.
Publicado: (2022)

Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas
por: Meireles Da Costa, Nathalia, et al.
Publicado: (2021)

Adjuvant radiotherapy in high-risk cutaneous squamous cell cancer of the head and neck in immunosuppressed patients
por: Koyfman, Shlomo A., et al.
Publicado: (2015)

Integrated Analysis of RNA-Binding Proteins Associated With the Prognosis and Immunosuppression in Squamous Cell Carcinoma of Head and Neck
por: Hu, Guangsheng, et al.
Publicado: (2021)

Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma
por: Yang, Jing, et al.
Publicado: (2020)

The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma
por: Grsic, Kresimir, et al.
Publicado: (2016)

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
por: Eun, Young-Gyu, et al.
Publicado: (2017)

The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma
por: Zhong, Feng, et al.
Publicado: (2020)

The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
por: Paluszczak, Jarosław
Publicado: (2020)

The prognostic significance of tumor deposits in patients with head and neck squamous cell carcinomas
por: Yu, Shuting, et al.
Publicado: (2021)

The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma
por: Jiang, Wenmei, et al.
Publicado: (2023)

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
por: Laban, Simon, et al.
Publicado: (2017)

Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma
por: Wang, Juncheng, et al.
Publicado: (2021)

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
por: Yang, Xueming, et al.
Publicado: (2023)

Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India
por: Sarmah, Neelanjana, et al.
Publicado: (2019)

Prognostic Significance of Vitamin D Receptor Polymorphisms in Head and Neck Squamous Cell Carcinoma
por: Hama, Takanori, et al.
Publicado: (2011)

Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
por: Kanke, Minoru, et al.
Publicado: (2000)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment
por: Wu, Danli, et al.
Publicado: (2015)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck
por: Kunder, Shreya, et al.
Publicado: (2021)

Mining database for the expression and clinical significance of STAT family in head and neck squamous cell carcinomas
por: Ni, Haosheng, et al.
Publicado: (2020)

Elevated expression of MKRN3 in squamous cell carcinoma of the head and neck and its clinical significance
por: Zhang, Shuiting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_esgtv54i63genh6obspiu1r32u